ArrowMark Colorado Holdings’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-113
Closed -$19K 301
2016
Q3
$19K Buy
+113
New +$19.1K ﹤0.01% 320
2014
Q2
Sell
-113
Closed -$14K 333
2014
Q1
$14K Hold
113
﹤0.01% 302
2013
Q4
$13K Buy
+113
New +$12.9K ﹤0.01% 313
2013
Q3
Sell
-113
Closed -$12.3K 302
2013
Q2
$11K Buy
+113
New +$11.7K ﹤0.01% 132

Other funds holding AMGN

ArrowMark Colorado Holdings's AMGN Position: Q4 2016 in Review

ArrowMark Colorado Holdings sold out of Amgen (AMGN) in Q4 2016, closing a stake of 113 shares — an estimated $19K sold.

ArrowMark Colorado Holdings first reported a position in AMGN in Q2 2013 and held it in 4 quarters. The position peaked at $19K in Q3 2016. 1,541 funds tracked by Wall St. Rank hold AMGN as of Q4 2016.

  • ArrowMark Colorado Holdings reported no remaining Amgen position as of Q4 2016 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 113 Amgen shares in Q4 2016, an estimated $19K.
  • ArrowMark Colorado Holdings first reported a position in Amgen in Q2 2013 and held it in 4 quarters.
  • ArrowMark Colorado Holdings's Amgen position peaked at $19K in Q3 2016.
  • 1,541 funds tracked by Wall St. Rank held Amgen as of Q4 2016.

Based on ArrowMark Colorado Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.